Canada markets open in 7 hours 45 minutes

RepliCel Life Sciences Inc. (RP.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4100+0.0500 (+13.89%)
At close: 3:50PM EST
Currency in CAD

Valuation Measures

Market Cap (intraday) 514.04M
Enterprise Value 314.25M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)55.59
Price/Book (mrq)N/A
Enterprise Value/Revenue 356.41
Enterprise Value/EBITDA 6-8.15

Trading Information

Stock Price History

Beta (5Y Monthly) 0.84
52-Week Change 316.13%
S&P500 52-Week Change 333.30%
52 Week High 30.5800
52 Week Low 30.1000
50-Day Moving Average 30.3531
200-Day Moving Average 30.2276

Share Statistics

Avg Vol (3 month) 352.8k
Avg Vol (10 day) 329.16k
Shares Outstanding 534.25M
Float 20.05M
% Held by Insiders 140.67%
% Held by Institutions 10.00%
Shares Short (Feb. 25, 2021) 47.38k
Short Ratio (Feb. 25, 2021) 40.11
Short % of Float (Feb. 25, 2021) 40.03%
Short % of Shares Outstanding (Feb. 25, 2021) 40.02%
Shares Short (prior month Jan. 28, 2021) 426.41k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Aug. 09, 2016
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Aug. 09, 2016

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2019
Most Recent Quarter (mrq)Sep. 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-693.03%

Management Effectiveness

Return on Assets (ttm)-182.35%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)252.61k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)0.00%
Gross Profit (ttm)353.74k
EBITDA -1.75M
Net Income Avi to Common (ttm)-1.9M
Diluted EPS (ttm)-0.0650
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)65.37k
Total Cash Per Share (mrq)0
Total Debt (mrq)570.65k
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.05
Book Value Per Share (mrq)-0.14

Cash Flow Statement

Operating Cash Flow (ttm)-1.27M
Levered Free Cash Flow (ttm)421.95k